$PBH
Prestige Consumer Healthcare Inc

2020 Q2 Form 10-Q Financial Statement

#000129594720000026 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $229.4M $232.2M
YoY Change -1.19% -8.59%
Cost Of Revenue $95.53M $98.09M
YoY Change -2.61% -13.47%
Gross Profit $133.9M $134.1M
YoY Change -0.15% -4.66%
Gross Profit Margin 58.36% 57.75%
Selling, General & Admin $47.70M $56.50M
YoY Change -15.58% -7.53%
% of Gross Profit 35.63% 42.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.467M $7.061M
YoY Change 5.75% -15.66%
% of Gross Profit 5.58% 5.27%
Operating Expenses $53.75M $62.58M
YoY Change -14.11% -8.15%
Operating Profit $80.12M $71.49M
YoY Change 12.08% -1.38%
Interest Expense -$21.90M -$25.00M
YoY Change -12.4% -3.47%
% of Operating Profit -27.33% -34.97%
Other Income/Expense, Net -$10.00K -$416.0K
YoY Change -97.6% 378.16%
Pretax Income $58.20M $46.05M
YoY Change 26.38% -0.88%
Income Tax $14.46M $12.13M
% Of Pretax Income 24.85% 26.33%
Net Earnings $43.71M $33.93M
YoY Change 28.83% -1.57%
Net Earnings / Revenue 19.05% 14.61%
Basic Earnings Per Share $0.87 $0.66
Diluted Earnings Per Share $0.86 $0.65
COMMON SHARES
Basic Shares Outstanding 50.26M shares 51.70M shares
Diluted Shares Outstanding 50.81M shares 52.05M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.90M $29.00M
YoY Change 99.66% -15.45%
Cash & Equivalents $57.94M $29.04M
Short-Term Investments
Other Short-Term Assets $8.500M $9.200M
YoY Change -7.61% -15.6%
Inventory $116.8M $129.4M
Prepaid Expenses
Receivables $112.3M $142.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $295.6M $310.5M
YoY Change -4.82% -1.26%
LONG-TERM ASSETS
Property, Plant & Equipment $58.33M $51.39M
YoY Change 13.5% -2.03%
Goodwill $577.1M $578.3M
YoY Change -0.2% -5.65%
Intangibles $2.483B $2.501B
YoY Change -0.73% -8.12%
Long-Term Investments
YoY Change
Other Assets $2.903M $3.038M
YoY Change -4.44% -11.04%
Total Long-Term Assets $3.155B $3.150B
YoY Change 0.14% -8.8%
TOTAL ASSETS
Total Short-Term Assets $295.6M $310.5M
Total Long-Term Assets $3.155B $3.150B
Total Assets $3.450B $3.461B
YoY Change -0.31% -8.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.35M $62.11M
YoY Change -47.91% -20.78%
Accrued Expenses $88.70M $75.70M
YoY Change 17.17% 18.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.200M
YoY Change
Total Short-Term Liabilities $131.9M $143.5M
YoY Change -8.06% 0.87%
LONG-TERM LIABILITIES
Long-Term Debt $1.621B $1.779B
YoY Change -8.92% -10.75%
Other Long-Term Liabilities $25.26M $19.94M
YoY Change 26.66% -13.6%
Total Long-Term Liabilities $1.646B $1.799B
YoY Change -8.53% -10.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $131.9M $143.5M
Total Long-Term Liabilities $1.646B $1.799B
Total Liabilities $2.223B $2.359B
YoY Change -5.76% -9.51%
SHAREHOLDERS EQUITY
Retained Earnings $887.8M $735.7M
YoY Change 20.67% -0.25%
Common Stock $539.0K $537.0K
YoY Change 0.37% 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $118.9M $89.49M
YoY Change 32.82% 49.33%
Treasury Stock Shares 3.750M shares 2.848M shares
Shareholders Equity $1.227B $1.102B
YoY Change
Total Liabilities & Shareholders Equity $3.450B $3.461B
YoY Change -0.31% -8.17%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $43.71M $33.93M
YoY Change 28.83% -1.57%
Depreciation, Depletion And Amortization $7.467M $7.061M
YoY Change 5.75% -15.66%
Cash From Operating Activities $75.15M $52.78M
YoY Change 42.4% -5.51%
INVESTING ACTIVITIES
Capital Expenditures $2.553M $1.956M
YoY Change 30.52% -20.78%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.553M -$1.956M
YoY Change 30.52% -20.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $28.77M
YoY Change -100.0% -42.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$111.4M -$49.29M
YoY Change 125.93% -4.07%
NET CHANGE
Cash From Operating Activities $75.15M $52.78M
Cash From Investing Activities -$2.553M -$1.956M
Cash From Financing Activities -$111.4M -$49.29M
Net Change In Cash -$36.82M $1.512M
YoY Change -2535.12% -12.14%
FREE CASH FLOW
Cash From Operating Activities $75.15M $52.78M
Capital Expenditures $2.553M $1.956M
Free Cash Flow $72.60M $50.82M
YoY Change 42.86% -4.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001295947
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-32433
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
PRESTIGE CONSUMER HEALTHCARE INC.
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1297589
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2020Q2 dei City Area Code
CityAreaCode
914
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
524-6800
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
660 White Plains Road
CY2020Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2020Q2 dei Trading Symbol
TradingSymbol
PBH
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50188863 shares
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2020Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
94124000 USD
CY2019Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
97100000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1402000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
987000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
95526000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
98087000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
133868000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
134067000 USD
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
27750000 USD
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
34801000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19934000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21706000 USD
CY2020Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6065000 USD
CY2019Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6074000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
53749000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
62581000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80119000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
71486000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
43000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
21965000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25063000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-416000 USD
CY2020Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-21951000 USD
CY2019Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-25436000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
58168000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
46050000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14462000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12125000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50264000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51697000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50808000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52047000 shares
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10590000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
309000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10899000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-224000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54605000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33701000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57941000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94760000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20106000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20194000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
112324000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
150517000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
116811000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
116026000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8488000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4351000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
295564000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
365654000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58325000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55988000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27659000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28888000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5517000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5842000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
577128000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
575179000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2483051000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2479391000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2903000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2963000 USD
CY2020Q2 us-gaap Assets
Assets
3450147000 USD
CY2020Q1 us-gaap Assets
Assets
3513905000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
32352000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
62375000 USD
CY2020Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
24738000 USD
CY2020Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
9911000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5450000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5612000 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1230000 USD
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1220000 USD
CY2020Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
68159000 USD
CY2020Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
70763000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
131929000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
149881000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1620641000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1730300000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
417230000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
407812000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23762000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24877000 USD
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4314000 USD
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4626000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25257000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25438000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
2223133000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
2342934000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53939000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53805000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
539000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
538000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
490795000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
488116000 USD
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3750000 shares
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3719000 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
118865000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
117623000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33262000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-44161000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
887807000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
844101000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1227014000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1170971000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3450147000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3513905000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1170971000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1464000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1216000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1242000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10899000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1227014000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1095831000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1381000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29565000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
275000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-224000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1101623000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7467000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7061000 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-42000 USD
CY2019Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-20000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6147000 USD
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4206000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1400000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
851000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1464000 USD
CY2019Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1368000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
109000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1381000 USD
CY2020Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1831000 USD
CY2019Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1338000 USD
CY2020Q2 pbh Interest Expense Related To Right Of Use Asset
InterestExpenseRelatedToRightOfUseAsset
50000 USD
CY2019Q2 pbh Interest Expense Related To Right Of Use Asset
InterestExpenseRelatedToRightOfUseAsset
0 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39734000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5808000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8939000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4019000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4335000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-32386000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5306000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11588000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7616000 USD
CY2020Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1812000 USD
CY2019Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
93000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75154000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52777000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2553000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1956000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2553000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1956000 USD
CY2020Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56000000 USD
CY2019Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2020Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2019Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 USD
CY2020Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
55000000 USD
CY2019Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000 USD
CY2020Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
336000 USD
CY2019Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1216000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
275000 USD
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1242000 USD
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
799000 USD
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2019Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28766000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-111362000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49290000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1942000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-19000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36819000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1512000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94760000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27530000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57941000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29042000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
5571000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
19966000 USD
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
2182000 USD
CY2019Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1807000 USD
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.  Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.
CY2020Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
9279000 USD
CY2020Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
9803000 USD
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
223000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
355000 USD
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
107309000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
105868000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
116811000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
116026000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4200000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6500000 USD
CY2020Q1 us-gaap Goodwill Gross
GoodwillGross
738890000 USD
CY2020Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163711000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
575179000 USD
CY2020Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1949000 USD
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
740839000 USD
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163711000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
577128000 USD
CY2020Q1 pbh Intangible Assets Gross
IntangibleAssetsGross
2655132000 USD
CY2020Q2 pbh Intangible Assets Translation Adjustments Gain Loss
IntangibleAssetsTranslationAdjustmentsGainLoss
8689000 USD
CY2020Q2 pbh Intangible Assets Gross
IntangibleAssetsGross
2663821000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
175741000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4905000 USD
CY2020Q2 pbh Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments Gain Loss
FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
-124000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
180770000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2483051000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14725000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
19633000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
19633000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
19604000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
17560000 USD
CY2020Q2 pbh Us Finite Lived Intangible Asset Expected Amortization After Year Four
UsFiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
118205000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
209360000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
325000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
50000 USD
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1697000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1216000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
11707000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
16599000 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
54000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
914000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
13748000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
16924000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5250000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1052000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
6302000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6585000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1404000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Due Year One
OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
7989000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6317000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1404000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Due Year Two
OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
7721000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6304000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1404000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Due Year Three
OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
7708000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4132000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
700000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Due Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
4832000 USD
CY2020Q2 pbh Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
4974000 USD
CY2020Q2 pbh Finance Lease Liability To Be Paid Due After Year Four
FinanceLeaseLiabilityToBePaidDueAfterYearFour
0 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payments Due After Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
4974000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33562000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
5964000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
39526000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4350000 USD
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
420000 USD
CY2020Q2 pbh Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
4770000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
29212000 USD
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
5544000 USD
CY2020Q2 pbh Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
34756000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M10D
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0527
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0355
CY2020Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
34832000 USD
CY2020Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
34450000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6254000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13393000 USD
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1009000 USD
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1491000 USD
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9622000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3210000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3502000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4183000 USD
CY2020Q2 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
3468000 USD
CY2020Q1 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
5628000 USD
CY2020Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1612000 USD
CY2020Q1 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1917000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7860000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6491000 USD
CY2020Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
68159000 USD
CY2020Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
70763000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1634000000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1745000000 USD
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
13359000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
14700000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1620641000 USD
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1730300000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1234000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2020Q2 pbh Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
400000000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1634000000 USD
CY2020Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
2 agreement
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52047000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000.0 shares
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 pbh Voting Rights Number Of Votes Per Common Share Owned
VotingRightsNumberOfVotesPerCommonShareOwned
1 vote
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
1361000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
1453000 USD
CY2020 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2020Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33925000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50264000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51697000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
544000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
350000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50808000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
2500000 shares
CY2014Q2 pbh Sharebased Compensation Arrangementby Sharebased Payment Award Extensionof Expiration Period
SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod
P10Y
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1000000.0 shares
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1464000000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1381000000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
112000000 USD
CY2019Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
210000000 USD
CY2020Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
5781000000 USD
CY2019Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
6099000000 USD
CY2020Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
944000000 USD
CY2019Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
434000000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11700000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1100000 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
944600 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
38.45
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
302700 shares
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.53
CY2019Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9300 shares
CY2019Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
29.46
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
95900 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
42.62
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1142100 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
36.07
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2540000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
628600 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.70
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2206000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1020200 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.90
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
249900 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
39.98
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60500 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.10
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1209600 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.53
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5770000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
701500 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
39.36
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3874000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.249
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
CY2020Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
525000 USD
CY2019Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
577000 USD
CY2020Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
647000 USD
CY2019Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
721000 USD
CY2020Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-122000 USD
CY2019Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-144000 USD
CY2020Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
113 manufacturer
CY2019Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
113 manufacturer
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
95526000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
133868000 USD
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
27750000 USD
CY2020Q2 pbh Contribution Margin
ContributionMargin
106118000 USD
CY2020Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
25999000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80119000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
98087000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
134067000 USD
CY2019Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
34801000 USD
CY2019Q2 pbh Contribution Margin
ContributionMargin
99266000 USD
CY2019Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
27780000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
71486000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232154000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
577128000 USD
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2273691000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
209360000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2483051000 USD
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3060179000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
575179000 USD
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2265331000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
214060000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2479391000 USD
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3054570000 USD

Files In Submission

Name View Source Status
0001295947-20-000026-index-headers.html Edgar Link pending
0001295947-20-000026-index.html Edgar Link pending
0001295947-20-000026.txt Edgar Link pending
0001295947-20-000026-xbrl.zip Edgar Link pending
exhibit3112020-06x30.htm Edgar Link pending
exhibit3122020-06x30.htm Edgar Link pending
exhibit3212020-06x30.htm Edgar Link pending
exhibit3222020-06x30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pbh-20200630.htm Edgar Link pending
pbh-20200630.xsd Edgar Link pending
pbh-20200630_cal.xml Edgar Link unprocessable
pbh-20200630_def.xml Edgar Link unprocessable
pbh-20200630_g1.jpg Edgar Link pending
pbh-20200630_htm.xml Edgar Link completed
pbh-20200630_lab.xml Edgar Link unprocessable
pbh-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending